BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Mallinckrodt
Baxter
Fish and Richardson
Argus Health
Fuji
Chubb
Julphar
Daiichi Sankyo
McKesson

Generated: January 22, 2018

DrugPatentWatch Database Preview

ZERIT Drug Profile

« Back to Dashboard

Which patents cover Zerit, and what generic alternatives are available?

Zerit is a drug marketed by Bristol Myers Squibb and is included in three NDAs. There is one patent protecting this drug.

The generic ingredient in ZERIT is stavudine. There are fourteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the stavudine profile page.

US Patents and Regulatory Information for ZERIT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb ZERIT stavudine CAPSULE;ORAL 020412-001 Jun 24, 1994 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bristol Myers Squibb ZERIT XR stavudine CAPSULE, EXTENDED RELEASE;ORAL 021453-001 Dec 31, 2002 DISCN No No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Bristol Myers Squibb ZERIT stavudine CAPSULE;ORAL 020412-004 Jun 24, 1994 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bristol Myers Squibb ZERIT XR stavudine CAPSULE, EXTENDED RELEASE;ORAL 021453-002 Dec 31, 2002 DISCN No No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Bristol Myers Squibb ZERIT stavudine CAPSULE;ORAL 020412-002 Jun 24, 1994 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bristol Myers Squibb ZERIT stavudine CAPSULE;ORAL 020412-003 Jun 24, 1994 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bristol Myers Squibb ZERIT stavudine FOR SOLUTION;ORAL 020413-001 Sep 6, 1996 AA RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bristol Myers Squibb ZERIT stavudine CAPSULE;ORAL 020412-005 Jun 24, 1994 AB RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bristol Myers Squibb ZERIT XR stavudine CAPSULE, EXTENDED RELEASE;ORAL 021453-004 Dec 31, 2002 DISCN No No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Bristol Myers Squibb ZERIT XR stavudine CAPSULE, EXTENDED RELEASE;ORAL 021453-003 Dec 31, 2002 DISCN No No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for ZERIT

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bristol Myers Squibb ZERIT stavudine CAPSULE;ORAL 020412-001 Jun 24, 1994 ➤ Subscribe ➤ Subscribe
Bristol Myers Squibb ZERIT stavudine CAPSULE;ORAL 020412-005 Jun 24, 1994 ➤ Subscribe ➤ Subscribe
Bristol Myers Squibb ZERIT stavudine FOR SOLUTION;ORAL 020413-001 Sep 6, 1996 ➤ Subscribe ➤ Subscribe
Bristol Myers Squibb ZERIT stavudine CAPSULE;ORAL 020412-002 Jun 24, 1994 ➤ Subscribe ➤ Subscribe
Bristol Myers Squibb ZERIT stavudine CAPSULE;ORAL 020412-003 Jun 24, 1994 ➤ Subscribe ➤ Subscribe
Bristol Myers Squibb ZERIT stavudine CAPSULE;ORAL 020412-004 Jun 24, 1994 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Moodys
Harvard Business School
Chubb
Fish and Richardson
Federal Trade Commission
Julphar
Fuji
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot